At #AACR26, Mayo Clinic researchers share findings that include uncovering ancestry-associated epigenetic differences in CLL, identifying biomarkers to guide immunotherapy response and understanding cardiovascular disease in AYA breast cancer patients. https://t.co/Tk1pZkImOu